FT819 clinical trials

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

This study is testing a new medicine called FT819 for serious autoimmune diseases like lupus and vasculitis. It's looking at how safe it is and how well it works to reduce disease activity, especially in those who haven't responded to other treatments.